ABSTRACT
The authors report their experience of the ultrasonic follow-up of endometriomas after laparoscopic enucleation. Fifty women with sixty-six endometriomas were treated: the average diameter of the endometriomas is 4.2 cm. The clinical and ultrasonic follow-up of 21 months shows: -the disappearance of the ovary's solution of continuity after laparoscopic enucleation of the endometriomas; -the persistence of deep endometriomas; -the presence of residual fragments of the endometrioma's capsule; -the appearance of relapsing endometriomas.
Subject(s)
Endometriosis/diagnostic imaging , Endometriosis/surgery , Laparoscopy , Adolescent , Adult , Female , Follow-Up Studies , Humans , Recurrence , Time Factors , UltrasonographyABSTRACT
The Authors carried out a retrospective examination of data relating to 241 patients undergoing radical hysterectomy with pelvic lymphadenectomy between 1970 and 1991. The basic aim of the study was to identify and quantify complications correlated to radical hysterectomy using the Wertheim-Meigs method. Surgery was performed in 223 cases due to cervical cancer, in 13 cases due to endometrial cancer, in 3 cases due to vaginal cancer and in 2 due to ovarian cancer with secondary extension to the uterus. Complications were subdivided into intraoperative and postoperative. Intraoperative complications involved the urinary tract in 4.5% and other apparatus (intestinal and nervous lesions, hemorrhage due to vascular damage) in 8.7% of cases. Postoperative complications were classified as follows: 35.2% involving the urinary tract (fistula 20.3% and vesical dysfunction 14.9%) and 8% involving other organs or systems (infections, neuropathy, pelvic lymphocele, pathologies of intestinal canalization, etc.). Lastly, the Authors examined the individual complications of radical hysterectomy, focusing attention in particular on vesicourethral dyskinesia, in the light of the physiopathological mechanisms reported in the literature. The mean rate of complications in the series examined here was substantially comparable to that reported by other Authors.
Subject(s)
Hysterectomy/adverse effects , Adult , Aged , Female , Humans , Middle Aged , Morbidity , Retrospective StudiesABSTRACT
The risks connected with children's cerebral lesions are examined by means of two different surveys related to a retrospective study over a period of about 10 years. One of these surveys is clinical and is based in the obstetric case history of children carrying psychomotor handicaps. The other survey is instrumental and concerns 100 cases of pathologic cardiotocography during labour associated with fetal suffering. The results of border surveys are discusses. For the assessment of the obstetric risk the sum of the pathologic conditions that emerged during pregnancy and delivery have to be taken into consideration. Cardiotocography is still a fundamental diagnostic examination to recognise the suffering fetus and the data collected real a close association between cardiotocography diagnosis and the conditions of the baby at the birth.
Subject(s)
Brain Damage, Chronic/embryology , Brain Diseases/embryology , Labor, Obstetric , Pregnancy , Brain Damage, Chronic/diagnosis , Brain Damage, Chronic/etiology , Brain Diseases/diagnosis , Brain Diseases/etiology , Cardiotocography , Female , Fetal Hypoxia/complications , Humans , Hypoxia, Brain/complications , Infant, Newborn , Prenatal Diagnosis/methods , PrognosisABSTRACT
The study reports on the follow-up in 25 cases of uterine sarcoma from 1979 to 1988. 56% of them are leiomyosarcoma, 28% mixed mullerian tumors and 16% sarcoma of the endometrial stroma. The women affected are mostly 40 to 70 years old; 80% of them are pluriparae, in menopause for 64% of them at the time of the diagnosis. Metrorrhagia is the initial symptom in 72% of the cases, 76% of which diagnosed after surgical intervention. The majority of the surgical interventions are integrated with chemo and/or radiotherapy. After three years 66.6% are surviving at the first stage, 33.4% at the second stage, none at the third stage.
Subject(s)
Leiomyosarcoma/epidemiology , Uterine Neoplasms/epidemiology , Adult , Aged , Endometrial Neoplasms/diagnosis , Endometrial Neoplasms/epidemiology , Endometrial Neoplasms/therapy , Female , Humans , Italy/epidemiology , Leiomyosarcoma/diagnosis , Leiomyosarcoma/therapy , Middle Aged , Neoplasms, Germ Cell and Embryonal/diagnosis , Neoplasms, Germ Cell and Embryonal/epidemiology , Neoplasms, Germ Cell and Embryonal/therapy , Survival Rate , Uterine Neoplasms/diagnosis , Uterine Neoplasms/therapySubject(s)
Bromocriptine/therapeutic use , Danazol/therapeutic use , Fibrocystic Breast Disease/drug therapy , Pregnadienes/therapeutic use , Progestins/therapeutic use , Tamoxifen/therapeutic use , Endocrine System Diseases/complications , Endocrine System Diseases/drug therapy , Female , Fibrocystic Breast Disease/etiology , HumansSubject(s)
Intrauterine Devices/adverse effects , Epidemiologic Methods , Female , Humans , Pregnancy , Pregnancy, Ectopic/etiology , RiskSubject(s)
Fibrinolysis , Pregnancy , Adolescent , Adult , Blood Coagulation , Female , Fibrinogen/analysis , Hemolysis , Humans , Middle Aged , Serum Globulins/metabolism , Time FactorsSubject(s)
Vulvar Neoplasms/diagnosis , Adult , Aged , Female , Humans , Middle Aged , Staining and LabelingSubject(s)
Meiosis , Oocytes/cytology , Ovum/cytology , Culture Techniques , Female , Humans , Staining and Labeling , Time FactorsSubject(s)
Chromosome Aberrations/etiology , Meiosis , Sex Chromosome Aberrations/etiology , Sex Chromosomes , Chromosome Disorders , Female , Humans , MaleSubject(s)
Bacterial Infections , Bacteriuria , Pregnancy Complications, Infectious , Puerperal Infection , Urinary Tract Infections , Adult , Female , Humans , PregnancySubject(s)
Androgen-Insensitivity Syndrome/pathology , Gonads/ultrastructure , Adolescent , Adult , Female , HumansABSTRACT
PIP: 50 women on estroprogestational contraceptive treatment, and 48 healthy controls were observed to examine antithrombin activity, heparin-thrombin activity, and fibrinogen. Antithrombin activity and heparin-thrombin activity decreased significantly in women under OC (oral contraception) treatment, while fibrinogen did not increase significantly. No correlation was found between duration of therapy and antithrombin activity decrease. It is possible that there are 2 groups of women, one with normal antithrombin activity, and one with reduced activity; this last group of patients could be more at risk of hypercoagulation accidents, and should be checked more often.^ieng